Chickens are vitally important in numerous countries as a primary food source and a major component of economic development. Efforts have been made to produce transgenic birds through pluripotent stem cell [primordial germ cells and embryonic stem cells (ESCs)] approaches to create animals with improved traits, such as meat and egg production or even disease resistance. However, these cell types have significant limitations because they are hard to culture long term while maintaining developmental plasticity. Induced pluripotent stem cells (iPSCs) are a novel class of stem cells that have proven to be robust, leading to the successful development of transgenic mice, rats, quail, and pigs and may potentially overcome the limitations of previous pluripotent stem cell systems in chickens. In this study we generated chicken (c) iPSCs from fibroblast cells for the first time using a nonviral minicircle reprogramming approach. ciPSCs demonstrated stem cell morphology and expressed key stem cell markers, including alkaline phosphatase, POU5F1, SOX2, NANOG, and SSEA-1. These cells were capable of rapid growth and expressed high levels of telomerase. Late-passage ciPSCs transplanted into stage X embryos were successfully incorporated into tissues of all three germ layers, and the gonads demonstrated significant cellular plasticity. These cells provide an exciting new tool to create transgenic chickens with broad implications for agricultural and transgenic animal fields at large.
Get full access to this article
View all access options for this article.
References
1.
AmitM., SharikiC., MarguletsV., and Itskovitz-EldorJ. (2004). Feeder layer- and serum-free culture of human embryonic stem cells. Biol. Reprod., 70, 837–845.
2.
BeardC., HochedlingerK., PlathK., WutzA., and JaenischR. (2006). Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis, 44, 23–28.
CaoH., YangP., PuY., SunX., YinH., ZhangY., LiY., LiuY., FangF., ZhangZ., TaoY., and ZhangX. (2012). Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins. Int. J. Biol. Sci., 8, 498–511.
5.
CarsienceR.S., ClarkM.E., Verrinder GibbinsA.M., and EtchesR.J. (1993). Germline chimeric chickens from dispersed donor blastodermal cells and compromised recipient embryos. Development, 117, 669–675.
6.
ChaudhryM.A., VitalisT.Z., BowenB.D., and PiretJ.M. (2008). Basal medium composition and serum or serum replacement concentration influences on the maintenance of murine embryonic stem cells. Cytotechnology, 58, 173–179.
7.
ChenZ., XuW.R., QianH., ZhuW., BuX.F., WangS., YanY.M., MaoF., GuH.B., CaoH.L., and XuX.J. (2009). Oct4, a novel marker for human gastric cancer. J. Surg. Oncol., 99, 414–419.
8.
ChenZ.Y., HeC.Y., EhrhardtA., and KayM.A. (2003). Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther., 8, 495–500.
9.
ChiouS.H., YuC.C., HuangC.Y., LinS.C., LiuC.J., TsaiT.H., ChouS.H., ChienC.S., KuH.H., and LoJ.F. (2008). Positive correlations of oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res., 14, 4085–4095.
10.
ChoJ., KingJ.S., QianX., HarwoodA.J., and ShearsS.B. (2008). Dephosphorylation of 2,3-bisphosphoglycerate by mipp expands the regulatory capacity of the rapoport-luebering glycolytic shunt. Proc. Natl. Acad. Sci. USA, 105, 5998–6003.
11.
CreuzetS., VincentC., and CoulyG. (2005). Neural crest derivatives in ocular and periocular structures. Int. J. Dev. Biol., 49, 161–171.
12.
DodgsonJ.B., and RomanovM. (2004). Use of chicken models for the analysis of human disease. Curr. Protoc. Hum. Genet. Unit. 15-5, DOI: 10.1002/0471142905.hg1505s40.
13.
EzashiT., TeluguB.P., AlexenkoA.P., SachdevS., SinhaS., and RobertsR.M. (2009). Derivation of induced pluripotent stem cells from pig somatic cells. Proc. Natl. Acad. Sci. USA, 106, 10993–10998.
14.
Francis-WestP.H., RobertsonK.E., EdeD.A., RodriguezC., Izpisua-BelmonteJ.C., HoustonB., BurtD.W., GribbinC., BrickellP.M., and TickleC. (1995). Expression of genes encoding bone morphogenetic proteins and sonic hedgehog in talpid (ta3) limb buds: Their relationships in the signalling cascade involved in limb patterning. Dev. Dyn., 203, 187–197.
15.
GloverJ.C., BoullandJ.L., HalasiG., and KasumacicN. (2009). Chimeric animal models in human stem cell biology. ILAR J, 51, 62–73.
16.
HanJ.Y. (2009). Germ cells and transgenesis in chickens. Comp. Immunol. Microbiol. Infect. Dis., 32, 61–80.
17.
HannaJ.H., SahaK., and JaenischR. (2010). Pluripotency and cellular reprogramming: Facts, hypotheses, unresolved issues. Cell, 143, 508–525.
18.
HuangB., LiT., Alonso-GonzalezL., GorreR., KeatleyS., GreenA., TurnerP., KallingappaP.K., VermaV., and ObackB. (2011). A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition. PLoS One, 6, e24501.
19.
HubnerK., FuhrmannG., ChristensonL.K., KehlerJ., ReinboldR., De La FuenteR., WoodJ., StraussJ.F.III, BoianiM., and ScholerH.R. (2003). Derivation of oocytes from mouse embryonic stem cells. Science, 300, 1251–1256.
20.
IvarieR. (2003). Avian transgenesis: Progress towards the promise. Trends Biotechnol, 21, 14–9.
21.
JamesD., LevineA.J., BesserD., and Hemmati-BrivanlouA. (2005). Tgfbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development, 132, 1273–1282.
22.
JiaF., WilsonK.D., SunN., GuptaD.M., HuangM., LiZ., PanettaN.J., ChenZ.Y., RobbinsR.C., KayM.A., LongakerM.T., and WuJ.C. (2010). A nonviral minicircle vector for deriving human ips cells. Nat. Methods, 7, 197–199.
23.
JonesT.D., UlbrightT.M., EbleJ.N., and ChengL. (2004). Oct4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin. Cancer Res., 10, 8544–8547.
24.
KhodadadiK., SumerH., PashaiaslM., LimS., WilliamsonM., and VermaP.J. (2012). Induction of pluripotency in adult equine fibroblasts without c-myc. Stem Cells Int., 2012, 429160.
25.
KimJ.N., ParkT.S., ParkS.H., ParkK.J., KimT.M., LeeS.K., LimJ.M., and HanJ.Y. (2010). Migration and proliferation of intact and genetically modified primordial germ cells and the generation of a transgenic chicken. Biol. Reprod., 82, 257–262.
KuesW.A., and NiemannH. (2011). Advances in farm animal transgenesis. Prev. Vet. Med., 102, 146–156.
28.
LaboskyP.A., BarlowD.P., and HoganB.L. (1994). Mouse embryonic germ (EG) cell lines: Transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (IGF2r) gene compared with embryonic stem (ES) cell lines. Development, 120, 3197–3204.
29.
LavialF., and PainB. (2010). Chicken embryonic stem cells as a non-mammalian embryonic stem cell model. Dev. Growth Differ., 52, 101–114.
30.
Le DouarinN.M. (1993). Embryonic neural chimaeras in the study of brain development. Trends Neurosci., 16, 64–72.
31.
Le DouarinN.M., TanK., HallonetM., and KinutaniM. (1993). Studying brain development with quail-chick neural chimeras. Kaibogaku Zasshi, 68, 152–161.
LeeA.Y., and LloydK.C. (2011). Rederivation of transgenic mice from ips cells derived from frozen tissue. Transgenic Res., 20, 167–175.
34.
LeightonP.A., van de LavoirM.C., DiamondJ.H., XiaC., and EtchesR.J. (2008). Genetic modification of primordial germ cells by gene trapping, gene targeting, and phiC31 integrase. Mol. Reprod. Dev., 75, 1163–1175.
35.
LiY., CangM., LeeA.S., ZhangK., and LiuD. (2011). Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS One, 6, e15947.
36.
LillicoS.G., McGrewM.J., ShermanA., and SangH.M. (2005). Transgenic chickens as bioreactors for protein-based drugs. Drug Discov. Today, 10, 191–196.
37.
LowryW.E., RichterL., YachechkoR., PyleA.D., TchieuJ., SridharanR., ClarkA.T., and PlathK. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA, 105, 2883–2888.
38.
LuY., WestF.D., JordanB.J., JordanE.T., WestR.C., YuP., HeY., BarriosM.A., ZhuZ., PetitteJ.N., BecksteadR.B., and SticeS.L. (2014). Induced pluripotency in chicken embryonic fibroblast results in a germ cell fate. Stem Cells Dev. (in press).
39.
LuY., WestF.D., JordanB.J., MumawJ.L., JordanE.T., Gallegos-CardenasA., BecksteadR.B., and SticeS.L. (2012). Avian-induced pluripotent stem cells derived using human reprogramming factors. Stem Cells Dev., 21, 394–403.
40.
MacdonaldJ., TaylorL., ShermanA., KawakamiK., TakahashiY., SangH.M., and McGrewM.J. (2012). Efficient genetic modification and germ-line transmission of primordial germ cells using piggybac and tol2 transposons. Proc. Natl. Acad. Sci. USA, 109, E1466–E1472.
41.
McCollK.A., ClarkeB., and DoranT.J. (2013). Role of genetically engineered animals in future food production. Aust. Vet. J., 91, 113–117.
42.
MotonoM., YamadaY., HattoriY., NakagawaR., NishijimaK., and IijimaS. (2010). Production of transgenic chickens from purified primordial germ cells infected with a lentiviral vector. J. Biosci. Bioeng., 109, 315–321.
43.
NayerniaK., NolteJ., MichelmannH.W., LeeJ.H., RathsackK., DrusenheimerN., DevA., WulfG., EhrmannI.E., ElliottD.J., OkpanyiV., ZechnerU., HaafT., MeinhardtA., and EngelW. (2006). In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev. Cell, 11, 125–132.
44.
OkitaK., IchisakaT., and YamanakaS. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448, 313–317.
45.
OkitaK., HongH., TakahashiK., and YamanakaS. (2010). Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat. Prot., 5, 418–428.
46.
PainB., ClarkM.E., ShenM., NakazawaH., SakuraiM., SamarutJ., and EtchesR.J. (1996). Long-term in vitro culture and characterisation of avian embryonic stem cells with multiple morphogenetic potentialities. Development, 122, 2339–2348.
47.
ParkT.S., JeongD.K., KimJ.N., SongG.H., HongY.H., LimJ.M., and HanJ.Y. (2003). Improved germline transmission in chicken chimeras produced by transplantation of gonadal primordial germ cells into recipient embryos. Biol. Reprod., 68, 1657–1662.
48.
PesceM., FarraceM.G., PiacentiniM., DolciS., and De FeliciM. (1993). Stem cell factor and leukemia inhibitory factor promote primordial germ cell survival by suppressing programmed cell death (apoptosis). Development, 118, 1089–1094.
RosselloR.A., ChenC.C., DaiR., HowardJ.T., HochgeschwenderU., and JarvisE.D. (2013). Mammalian genes induce partially reprogrammed pluripotent stem cells in non-mammalian vertebrate and invertebrate species. eLife, 2, e00036.
51.
SatoN., MeijerL., SkaltsounisL., GreengardP., and BrivanlouA.H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of wnt signaling by a pharmacological gsk-3-specific inhibitor. Nat. Med., 10, 55–63.
52.
Semple-RowlandS.L., LeeN.R., Van HooserJ.P., PalczewskiK., and BaehrW. (1998). A null mutation in the photoreceptor guanylate cyclase gene causes the retinal degeneration chicken phenotype. Proc. Natl. Acad. Sci. USA, 95, 1271–1276.
53.
ShamblottM.J., AxelmanJ., LittlefieldJ.W., BlumenthalP.D., HugginsG.R., CuiY., ChengL., and GearhartJ.D. (2001). Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc. Natl. Acad. Sci. USA, 98, 113–118.
54.
SongY., D'CostaS., PardueS.L., and PetitteJ.N. (2005). Production of germline chimeric chickens following the administration of a busulfan emulsion. Mol. Reprod. Dev., 70, 438–444.
55.
StaeheliP., RinderM., and KaspersB. (2010). Avian bornavirus associated with fatal disease in psittacine birds. J. Virol., 84, 6269–6275.
56.
StitzL., BilzerT., and PlanzO. (2002). The immunopathogenesis of borna disease virus infection. Front. Biosci., 7, d541–d555.
57.
TakahashiK., and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663–676.
58.
TakahashiK., TanabeK., OhnukiM., NaritaM., IchisakaT., TomodaK., and YamanakaS. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
59.
TamP.P., and RossantJ. (2003). Mouse embryonic chimeras: Tools for studying mammalian development. Development, 130, 6155–6163.
60.
ToyookaY., TsunekawaN., AkasuR., and NoceT. (2003). Embryonic stem cells can form germ cells in vitro. Proc. Natl. Acad. Sci. USA, 100, 11457–11462.
61.
TurnpennyL., BrickwoodS., SpallutoC.M., PiperK., CameronI.T., WilsonD.I., and HanleyN.A. (2003). Derivation of human embryonic germ cells: An alternative source of pluripotent stem cells. Stem Cells, 21, 598–609.
van de LavoirM.C., DiamondJ.H., LeightonP.A., Mather-LoveC., HeyerB.S., BradshawR., KerchnerA., HooiL.T., GessaroT.M., SwanbergS.E., DelanyM.E., and EtchesR.J. (2006a). Germline transmission of genetically modified primordial germ cells. Nature, 441, 766–769.
64.
van de LavoirM.C., Mather-LoveC., LeightonP., DiamondJ.H., HeyerB.S., RobertsR., ZhuL., Winters-DigiacintoP., KerchnerA., GessaroT., SwanbergS., DelanyM.E., and EtchesR.J. (2006b). High-grade transgenic somatic chimeras from chicken embryonic stem cells. Mech. Dev., 123, 31–41.
65.
VermaR., LiuJ., HollandM.K., Temple-SmithP., WilliamsonM., and VermaP.J. (2013). Nanog is an essential factor for induction of pluripotency in somatic cells from endangered felids. Biores. Open Access, 2, 72–76.
66.
WestF., and SticeS. (2011). Progress toward generating informative porcine biomedical models using induced pluripotent stem cells. Ann. NY Acad. Sci., 1245, 21–23.
67.
WestF.D., MumawJ.L., Gallegos-CardenasA., YoungA., and SticeS.L. (2010a). Human haploid cells differentiated from meiotic competent clonal germ cell lines that originated from embryonic stem cells. Stem Cells Dev., 20:1079–1088.
WestF.D., UhlE.W., LiuY., StoweH., LuY., YuP., Gallegos-CardenasA., PrattS.L., and SticeS.L. (2011). Brief report: Chimeric pigs produced from induced pluripotent stem cells demonstrate germline transmission and no evidence of tumor formation in young pigs. Stem Cells, 29, 1640–1643.
70.
YingQ.L., WrayJ., NicholsJ., Batlle-MoreraL., DobleB., WoodgettJ., CohenP., and SmithA. (2008). The ground state of embryonic stem cell self-renewal. Nature, 453, 519–523.
71.
YuJ., VodyanikM.A., Smuga-OttoK., Antosiewicz-BourgetJ., FraneJ.L., TianS., NieJ., JonsdottirG.A., RuottiV., StewartR., SlukvinII, and ThomsonJ.A. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318, 1917–1920.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
